What do studies and labels say about caffeine anhydrous dosage?

Tablet strengths and label directions
ProductStrengthLabel direction
Stay Awake (US over-the-counter)200 mg tablets1Adults and children 12 years of age and over: 1 tablet not more often than every 3 to 4 hours1
Alert Aid (US over-the-counter)200 mg tablets2Adults and children 12 years and over: 1 tablet not more often than every 3 to 4 hours2

Two US over-the-counter labels give 1 tablet of 200 mg not more often than every 3 to 4 hours, and the FDA cites 400 mg a day as an amount not generally associated with negative effects for most adults.123

Tablet strengths and label directions

The table is set at the top of the page

No capsule strength or powder pack size from a label appears in the sources read.

How much is too much a day?

The FDA has cited 400 mg a day as an amount not generally associated with negative effects for most adults, and adds that there is wide variation in both how sensitive people are to the effects of caffeine and how fast they eliminate it from the body.3 The FDA estimates toxic effects such as seizures can be seen with rapid consumption of around 1,200 mg.3

The FDA says pure and highly concentrated caffeine products are often marketed in bulk packaging with up to thousands of servings per container, and the difference between a safe and a toxic amount in these products is very small.4 The FDA adds that, for many of these products, volume measures such as teaspoons are not precise enough to calculate how many milligrams of caffeine are in the recommended serving size.4

What doses did trials use?

TrialDose and schedulePeopleLength
Trexler et al.300 mg caffeine anhydrous in a drink, 303 mg caffeine as coffee, or placebo, 30 minutes before testingFifty-six resistance-trained males enrolled, fifty-four completedSingle dose, two visits at least 48 hours apart5
Kaplan et al., 1997250 mg, 500 mg or placebo, single oral dosesTwelve healthy volunteersSingle-dose crossover6
Watson et al., 2002200 mg caffeine or placebo twice daily, then a caffeine challengeTwelve healthy volunteers1 week, crossover7
Lara et al.3 mg/kg/day caffeine in capsules or placebo, crossoverEleven healthy active participants20 consecutive days per treatment8
Drake et al., 2013400 mg in pill form at 6, 3 or 0 hours before habitual bedtime, placebo at the other timesHealthy normal sleepersFour nights per person, crossover9
Konidari et al. (CrossFit trial)7.1 ± 0.7 mg/kg anhydrous caffeine (200 mg tablets) or placebo, 60 minutes before a sessionTwelve healthy menOne dose per session, crossover with washout of at least seven days10
NCT03694886 (Univ. of Colorado)90 mg caffeine anhydrous in 8 ounces of water, or none (no results posted)120 participants in four parallel groupsSingle dose, phase 411

Trexler et al. gave a flat 300 mg (3–5 mg/kg) to people of 60 to 100 kg; leg press one-rep max improved more with coffee than with caffeine anhydrous, and neither improved strength more than placebo, while both attenuated sprint power reductions to a similar degree.5 In Konidari et al., a crossover trial of twelve healthy men, at least one side effect was reported by 67% of volunteers after caffeine and 25% after placebo.10

Does tolerance develop, and are there cycles?

In Lara et al., eleven healthy active participants took 3 mg/kg/day for 20 consecutive days; compared with placebo, peak cycling power in the incremental test rose by ~4.0 ±1.3%, and the summary says it did so for the first 15 days of ingestion; the authors say the results suggest progressive tolerance.8 Watson et al. (2002) gave twelve healthy volunteers 200 mg caffeine or placebo twice daily for 1 week; the authors conclude that tolerance is incomplete with respect to both peripheral or central effects of caffeine, and that tolerance was not demonstrated in performance or in improvements in positive aspects of mood.7 None of the trials read tests an on/off cycling schedule.

Mixing a powder in a drink

No label or leaflet found says which water, or how much, to mix with caffeine anhydrous powder. Trexler et al. mixed 300 mg caffeine anhydrous powder with noncaloric flavouring and 350 mL of water.5 No label or trial read gives an mg/mL concentration or U-100 syringe use for caffeine anhydrous, which is taken by mouth.

Storage

The Stay Awake 200 mg tablet label says to store at room temperature and avoid excessive heat (greater than 100°F) or humidity.1 The Alert Aid 200 mg tablet label says to store at 25°C (77°F), with excursions permitted between 15° and 30°C (59° to 86°F).2

Frequently asked questions

How does timing before bed matter?

The authors of Drake et al. (2013), a crossover trial, state that 400 mg of caffeine taken 0, 3 or even 6 hours prior to bedtime significantly disrupts sleep, and that even at 6 hours caffeine reduced sleep by more than 1 hour.9

What is a safe daily intake for healthy adults?

A 2017 systematic review by Wikoff and colleagues found the evidence generally supports that up to 400 mg caffeine/day in healthy adults is not associated with overt adverse cardiovascular, behavioural, reproductive, developmental, acute or bone effects.12

References

  1. Spirit Pharmaceuticals (DailyMed). Stay Awake (CAFFEINE 200 MG). 2024. dailymed.nlm.nih.gov
  2. DailyMed. Good Neighbor Pharmacy 44-226. 2026. dailymed.nlm.nih.gov
  3. US FDA. Spilling the Beans: How Much Caffeine is Too Much?. fda.gov
  4. US FDA. Pure and Highly Concentrated Caffeine. fda.gov
  5. Eur J Sport Sci. Effects of coffee and caffeine anhydrous on strength and sprint performance. 2015. pmc.ncbi.nlm.nih.gov
  6. PubMed. Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. 1997. pubmed.ncbi.nlm.nih.gov
  7. PMC. Central and peripheral effects of sustained caffeine use: tolerance is incomplete. pmc.ncbi.nlm.nih.gov
  8. PMC. Time course of tolerance to the performance benefits of caffeine. 2019. pmc.ncbi.nlm.nih.gov
  9. PMC. Caffeine Effects on Sleep Taken 0, 3, or 6 Hours before Going to Bed. pmc.ncbi.nlm.nih.gov
  10. Nutrients. Effects of an Acute High Dose of Caffeine on Physiological Responses and Performance During a Strength-Focused CrossFit ® Workout: A Randomized, Double-Blind, Crossover Study. 2025. pmc.ncbi.nlm.nih.gov
  11. ClinicalTrials.gov. NCT03694886: The Effect of Tablet Size on Cognitive Performance Caffeine. 2019. clinicaltrials.gov
  12. PubMed. Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children. 2017. pubmed.ncbi.nlm.nih.gov